Squarepoint’s Myovant Sciences Ltd. MYOV Stock Holding History

Squarepoint’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,820	Closed	-$588K	–	3995
2022 Q4	$588K	Sell	21,820 -62,486	-74%	-$1.64M	﹤0.01%	2178
2022 Q3	$1.51M	Buy	+84,306	New	+$1.35M	0.01%	1499
2021 Q1	–	Sell	-28,547	Closed	-$788K	–	3789
2020 Q4	$788K	Buy	28,547 +15,251	+115%	+$297K	0.01%	1482
2020 Q3	$187K	Sell	13,296 -7,657	-37%	-$142K	﹤0.01%	2121
2020 Q2	$432K	Buy	+20,953	New	+$285K	0.01%	1388

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Squarepoint's MYOV Position: Q1 2023 in Review

Squarepoint sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 21,820 shares — an estimated $588K sold.

Squarepoint first reported a position in MYOV in Q2 2020 and held it in 5 quarters. The position peaked at $1.51M in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Squarepoint reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 21,820 Myovant Sciences Ltd. shares in Q1 2023, an estimated $588K.
Squarepoint first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 5 quarters.
Squarepoint's Myovant Sciences Ltd. position peaked at $1.51M in Q3 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.